163 related articles for article (PubMed ID: 26087467)
1. Biophysical elucidation of the mechanism of enhanced drug release and topical delivery from polymeric film-forming systems.
Garvie-Cook H; Frederiksen K; Petersson K; Guy RH; Gordeev SN
J Control Release; 2015 Aug; 212():103-12. PubMed ID: 26087467
[TBL] [Abstract][Full Text] [Related]
2. Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin.
Frederiksen K; Guy RH; Petersson K
Eur J Pharm Biopharm; 2015 Apr; 91():9-15. PubMed ID: 25595740
[TBL] [Abstract][Full Text] [Related]
3. Characterization of topical film-forming systems using atomic force microscopy and Raman microspectroscopy.
Garvie-Cook H; Frederiksen K; Petersson K; Guy RH; Gordeev S
Mol Pharm; 2015 Mar; 12(3):751-7. PubMed ID: 25586343
[TBL] [Abstract][Full Text] [Related]
4. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
[TBL] [Abstract][Full Text] [Related]
7. The potential of polymeric film-forming systems as sustained delivery platforms for topical drugs.
Frederiksen K; Guy RH; Petersson K
Expert Opin Drug Deliv; 2016; 13(3):349-60. PubMed ID: 26609868
[TBL] [Abstract][Full Text] [Related]
8. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting.
Md S; Kuldeep Singh JKA; Waqas M; Pandey M; Choudhury H; Habib H; Hussain F; Hussain Z
Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554
[TBL] [Abstract][Full Text] [Related]
9. Film-forming formulations containing porous silica for the sustained delivery of actives to the skin.
Heck R; Hermann S; Lunter DJ; Daniels R
Eur J Pharm Biopharm; 2016 Nov; 108():1-8. PubMed ID: 27553263
[TBL] [Abstract][Full Text] [Related]
10. Dermatopharmacokinetics of betamethasone 17-valerate: influence of formulation viscosity and skin surface cleaning procedure.
Wiedersberg S; Leopold CS; Guy RH
Eur J Pharm Biopharm; 2009 Feb; 71(2):362-6. PubMed ID: 18940255
[TBL] [Abstract][Full Text] [Related]
11. Potential of biocompatible polymeric ultra-thin films, nanosheets, as topical and transdermal drug delivery devices.
Hatanaka T; Saito T; Fukushima T; Todo H; Sugibayashi K; Umehara S; Takeuchi T; Okamura Y
Int J Pharm; 2019 Jun; 565():41-49. PubMed ID: 31022503
[TBL] [Abstract][Full Text] [Related]
12. Application of water-soluble polyvinyl alcohol-based film patches on laser microporated skin facilitates intradermal macromolecule and nanoparticle delivery.
Engelke L; Winter G; Engert J
Eur J Pharm Biopharm; 2018 Jul; 128():119-130. PubMed ID: 29660407
[TBL] [Abstract][Full Text] [Related]
13. Effective topical delivery systems for corticosteroids: dermatological and histological evaluations.
Eroğlu İ; Azizoğlu E; Özyazıcı M; Nenni M; Gürer Orhan H; Özbal S; Tekmen I; Ertam İ; Ünal İ; Özer Ö
Drug Deliv; 2016 Jun; 23(5):1502-13. PubMed ID: 25259424
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles.
Zhang J; Smith E
J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362
[TBL] [Abstract][Full Text] [Related]
15. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy.
Franz TJ; Parsell DA; Halualani RM; Hannigan JF; Kalbach JP; Harkonen WS
Int J Dermatol; 1999 Aug; 38(8):628-32. PubMed ID: 10487457
[TBL] [Abstract][Full Text] [Related]
16. Palm Olein Emulsion: a Novel Vehicle for Topical Drug Delivery of Betamethasone 17-Valerate.
Ahmad K; Win T; Jaffri JM; Edueng K; Taher M
AAPS PharmSciTech; 2018 Jan; 19(1):371-383. PubMed ID: 28744617
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo skin permeation and penetration of nonivamide from and in vivo skin tolerability of film-forming formulations containing porous silica.
Heck R; Lukić MŽ; Savić SD; Daniels R; Lunter DJ
Eur J Pharm Sci; 2017 Aug; 106():34-40. PubMed ID: 28546105
[TBL] [Abstract][Full Text] [Related]
18. Deproteinized natural rubber film forming polymeric solutions for nicotine transdermal delivery.
Pichayakorn W; Suksaeree J; Boonme P; Amnuaikit T; Taweepreda W; Ritthidej GC
Pharm Dev Technol; 2013; 18(5):1111-21. PubMed ID: 22881292
[TBL] [Abstract][Full Text] [Related]
19. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.
Schlupp P; Blaschke T; Kramer KD; Höltje HD; Mehnert W; Schäfer-Korting M
Skin Pharmacol Physiol; 2011; 24(4):199-209. PubMed ID: 21346400
[TBL] [Abstract][Full Text] [Related]
20. Effects of permeation enhancers on flufenamic acid delivery in Ex vivo human skin by confocal Raman microscopy.
Pyatski Y; Zhang Q; Mendelsohn R; Flach CR
Int J Pharm; 2016 May; 505(1-2):319-28. PubMed ID: 27063850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]